Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Publisher Correction: Dynamic structural states of ClpB involved in its disaggregation function.

Uchihashi T, Watanabe YH, Nakazaki Y, Yamasaki T, Watanabe H, Maruno T, Ishii K, Uchiyama S, Song C, Murata K, Iino R, Ando T.

Nat Commun. 2019 Jul 12;10(1):3079. doi: 10.1038/s41467-019-11204-x.

2.

Dynamic structural states of ClpB involved in its disaggregation function.

Uchihashi T, Watanabe YH, Nakazaki Y, Yamasaki T, Watanabe H, Maruno T, Ishii K, Uchiyama S, Song C, Murata K, Iino R, Ando T.

Nat Commun. 2018 Jun 1;9(1):2147. doi: 10.1038/s41467-018-04587-w. Erratum in: Nat Commun. 2019 Jul 12;10(1):3079.

3.

Fusion protein analysis reveals the precise regulation between Hsp70 and Hsp100 during protein disaggregation.

Hayashi S, Nakazaki Y, Kagii K, Imamura H, Watanabe YH.

Sci Rep. 2017 Aug 17;7(1):8648. doi: 10.1038/s41598-017-08917-8.

4.

Mutant analysis of Cdt1's function in suppressing nascent strand elongation during DNA replication in Xenopus egg extracts.

Nakazaki Y, Tsuyama T, Azuma Y, Takahashi M, Tada S.

Biochem Biophys Res Commun. 2017 Sep 2;490(4):1375-1380. doi: 10.1016/j.bbrc.2017.07.034. Epub 2017 Jul 8.

PMID:
28694193
5.

Excess Cdt1 inhibits nascent strand elongation by repressing the progression of replication forks in Xenopus egg extracts.

Nakazaki Y, Tsuyama T, Seki M, Takahashi M, Enomoto T, Tada S.

Biochem Biophys Res Commun. 2016 Feb 5;470(2):405-410. doi: 10.1016/j.bbrc.2016.01.028. Epub 2016 Jan 8.

PMID:
26773501
6.

Biologic Activity of Autologous, Granulocyte-Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines.

Goldberg JM, Fisher DE, Demetri GD, Neuberg D, Allsop SA, Fonseca C, Nakazaki Y, Nemer D, Raut CP, George S, Morgan JA, Wagner AJ, Freeman GJ, Ritz J, Lezcano C, Mihm M, Canning C, Hodi FS, Dranoff G.

Clin Cancer Res. 2015 Jul 15;21(14):3178-86. doi: 10.1158/1078-0432.CCR-14-2932. Epub 2015 Mar 24.

7.

Angiogenic cytokines are antibody targets during graft-versus-leukemia reactions.

Piesche M, Ho VT, Kim H, Nakazaki Y, Nehil M, Yaghi NK, Kolodin D, Weiser J, Altevogt P, Kiefel H, Alyea EP, Antin JH, Cutler C, Koreth J, Canning C, Ritz J, Soiffer RJ, Dranoff G.

Clin Cancer Res. 2015 Mar 1;21(5):1010-8. doi: 10.1158/1078-0432.CCR-14-1956. Epub 2014 Dec 23.

8.

ClpB chaperone passively threads soluble denatured proteins through its central pore.

Nakazaki Y, Watanabe YH.

Genes Cells. 2014 Dec;19(12):891-900. doi: 10.1111/gtc.12188. Epub 2014 Oct 7.

9.

In vivo discovery of immunotherapy targets in the tumour microenvironment.

Zhou P, Shaffer DR, Alvarez Arias DA, Nakazaki Y, Pos W, Torres AJ, Cremasco V, Dougan SK, Cowley GS, Elpek K, Brogdon J, Lamb J, Turley SJ, Ploegh HL, Root DE, Love JC, Dranoff G, Hacohen N, Cantor H, Wucherpfennig KW.

Nature. 2014 Feb 6;506(7486):52-7. doi: 10.1038/nature12988. Epub 2014 Jan 29.

10.

Orientation of the amino-terminal domain of ClpB affects the disaggregation of the protein.

Mizuno S, Nakazaki Y, Yoshida M, Watanabe YH.

FEBS J. 2012 Apr;279(8):1474-84. doi: 10.1111/j.1742-4658.2012.08540.x. Epub 2012 Mar 16.

11.

Roles of conserved arginines in ATP-binding domains of AAA+ chaperone ClpB from Thermus thermophilus.

Yamasaki T, Nakazaki Y, Yoshida M, Watanabe YH.

FEBS J. 2011 Jul;278(13):2395-403. doi: 10.1111/j.1742-4658.2011.08167.x. Epub 2011 May 31.

12.

Active immunotherapy induces antibody responses that target tumor angiogenesis.

Schoenfeld J, Jinushi M, Nakazaki Y, Wiener D, Park J, Soiffer R, Neuberg D, Mihm M, Hodi FS, Dranoff G.

Cancer Res. 2010 Dec 15;70(24):10150-60. doi: 10.1158/0008-5472.CAN-10-1852.

13.
14.

Stability of the two wings of the coiled-coil domain of ClpB chaperone is critical for its disaggregation activity.

Watanabe YH, Nakazaki Y, Suno R, Yoshida M.

Biochem J. 2009 Jun 12;421(1):71-7. doi: 10.1042/BJ20082238.

PMID:
19351326
15.

Milk fat globule EGF-8 promotes melanoma progression through coordinated Akt and twist signaling in the tumor microenvironment.

Jinushi M, Nakazaki Y, Carrasco DR, Draganov D, Souders N, Johnson M, Mihm MC, Dranoff G.

Cancer Res. 2008 Nov 1;68(21):8889-98. doi: 10.1158/0008-5472.CAN-08-2147.

16.

TARC and RANTES enhance antitumor immunity induced by the GM-CSF-transduced tumor vaccine in a mouse tumor model.

Inoue H, Iga M, Xin M, Asahi S, Nakamura T, Kurita R, Nakayama M, Nakazaki Y, Takayama K, Nakanishi Y, Tani K.

Cancer Immunol Immunother. 2008 Sep;57(9):1399-411. doi: 10.1007/s00262-008-0476-7. Epub 2008 Feb 20.

PMID:
18286286
17.

Familial Turner mosaicism 46XX/45XO with brain calcification.

Maeda T, Sugano M, Guan JZ, Oyama J, Higuchi Y, Makino N, Hatakenaka M, Muta H, Nakayama M, Nakazaki Y, Kurita R, Hiroyama T, Suzuki T, Tani K.

J Neuropsychiatry Clin Neurosci. 2007 Summer;19(3):342-3. No abstract available.

PMID:
17827426
18.

MFG-E8-mediated uptake of apoptotic cells by APCs links the pro- and antiinflammatory activities of GM-CSF.

Jinushi M, Nakazaki Y, Dougan M, Carrasco DR, Mihm M, Dranoff G.

J Clin Invest. 2007 Jul;117(7):1902-13.

19.

Maternal-fetal transmission of Toxoplasma gondii in interferon-gamma deficient pregnant mice.

Shiono Y, Mun HS, He N, Nakazaki Y, Fang H, Furuya M, Aosai F, Yano A.

Parasitol Int. 2007 Jun;56(2):141-8. Epub 2007 Jan 24.

PMID:
17307382
20.

p51/p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate.

Kunisaki R, Ikawa S, Maeda T, Nakazaki Y, Kurita R, Harata M, Shutoh Y, Bai YS, Soda Y, Tanabe T, Dohi T, Kato R, Ikawa Y, Asano S, Tani K.

J Gene Med. 2006 Sep;8(9):1121-30.

PMID:
16832836
21.

Serial analysis of gene expression in progressing and regressing mouse tumors implicates the involvement of RANTES and TARC in antitumor immune responses.

Nakazaki Y, Hase H, Inoue H, Beppu Y, Meng XK, Sakaguchi G, Kurita R, Asano S, Nakamura Y, Tani K.

Mol Ther. 2006 Oct;14(4):599-606. Epub 2006 Jun 30.

22.

Tal1/Scl gene transduction using a lentiviral vector stimulates highly efficient hematopoietic cell differentiation from common marmoset (Callithrix jacchus) embryonic stem cells.

Kurita R, Sasaki E, Yokoo T, Hiroyama T, Takasugi K, Imoto H, Izawa K, Dong Y, Hashiguchi T, Soda Y, Maeda T, Suehiro Y, Tanioka Y, Nakazaki Y, Tani K.

Stem Cells. 2006 Sep;24(9):2014-22. Epub 2006 May 25.

23.

Antiangiogenic activity of BAI1 in vivo: implications for gene therapy of human glioblastomas.

Kang X, Xiao X, Harata M, Bai Y, Nakazaki Y, Soda Y, Kurita R, Tanaka T, Komine F, Izawa K, Kunisaki R, Setoyama M, Nishimori H, Natsume A, Sunamura M, Lozonshi L, Saitoh I, Tokino T, Asano S, Nakamura Y, Tani K.

Cancer Gene Ther. 2006 Apr;13(4):385-92.

PMID:
16244591
24.

Establishment of novel embryonic stem cell lines derived from the common marmoset (Callithrix jacchus).

Sasaki E, Hanazawa K, Kurita R, Akatsuka A, Yoshizaki T, Ishii H, Tanioka Y, Ohnishi Y, Suemizu H, Sugawara A, Tamaoki N, Izawa K, Nakazaki Y, Hamada H, Suemori H, Asano S, Nakatsuji N, Okano H, Tani K.

Stem Cells. 2005 Oct;23(9):1304-13. Epub 2005 Aug 18.

25.

Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.

Cho SG, Shuto Y, Soda Y, Nakazaki Y, Izawa K, Uchimaru K, Takahashi S, Tani K, Tojo A, Asano S.

Exp Hematol. 2004 Dec;32(12):1246-54.

PMID:
15588949
26.

Phase I study of autologous tumor vaccines transduced with the GM-CSF gene in four patients with stage IV renal cell cancer in Japan: clinical and immunological findings.

Tani K, Azuma M, Nakazaki Y, Oyaizu N, Hase H, Ohata J, Takahashi K, OiwaMonna M, Hanazawa K, Wakumoto Y, Kawai K, Noguchi M, Soda Y, Kunisaki R, Watari K, Takahashi S, Machida U, Satoh N, Tojo A, Maekawa T, Eriguchi M, Tomikawa S, Tahara H, Inoue Y, Yoshikawa H, Yamada Y, Iwamoto A, Hamada H, Yamashita N, Okumura K, Kakizoe T, Akaza H, Fujime M, Clift S, Ando D, Mulligan R, Asano S.

Mol Ther. 2004 Oct;10(4):799-816.

27.

An 85-year-old Japanese woman with Philadelphia chromosome-positive chronic myelogenous leukemia with del (5q) successfully treated by intermittent imatinib therapy.

Maeda T, Mutoh T, Muta H, Nakayama M, Nakajima Y, Ikuta T, Yasuda M, Etoh T, Shimizu K, Nakazaki Y, Hiroyama T, Somada S, Kurita R, Tani K, Shiratsuchi M, Nishimura J.

J Am Geriatr Soc. 2004 Oct;52(10):1783-4. No abstract available.

PMID:
15450069
28.

Hematopoietic activity of common marmoset CD34 cells isolated by a novel monoclonal antibody MA24.

Izawa K, Tani K, Nakazaki Y, Hibino H, Sugiyama H, Kawasaki A, Sasaki E, Nishioka C, Ishii H, Soda Y, Yagita H, Tanioka Y, Tojo A, Asano S.

Exp Hematol. 2004 Sep;32(9):843-51.

PMID:
15345286
29.
30.

Successful treatment of pure red cell aplasia with cyclosporin A and erythropoietin after thymectomy in a 88-year old woman.

Maeda T, Shiokawa S, Yoshikawa Y, Hiroyama T, Nakajima Y, Muta H, Nakayama M, Nakazaki Y, Akizuki S, Shimizu K, Mutoh T, Somada S, Kurita R, Shiratsuchi M, Makino N, Nishimura J, Tani K.

Haematologica. 2004 Jun 1;89(6 Suppl):ECR17.

31.

Haematopoietic progenitor cells from the common marmoset as targets of gene transduction by retroviral and adenoviral vectors.

Hibino H, Tani K, Sugiyama H, Suzuki S, Wu MS, Izawa K, Hase H, Nakazaki Y, Tanabe T, Ooi J, Izeki T, Tojo A, Saitoh I, Tanioka Y, Asano S.

Eur J Haematol. 2001 Apr;66(4):272-80.

PMID:
11380607
32.

MHC (major histocompatibility complex)-DRB genes and polymorphisms in common marmoset.

Wu MS, Tani K, Sugiyama H, Hibino H, Izawa K, Tanabe T, Nakazaki Y, Ishii H, Ohashi J, Hohjoh H, Iseki T, Tojo A, Nakamura Y, Tanioka Y, Tokunaga K, Asano S.

J Mol Evol. 2000 Sep;51(3):214-22.

PMID:
11029066
33.

Progress reports on immune gene therapy for stage IV renal cell cancer using lethally irradiated granulocyte-macrophage colony-stimulating factor-transduced autologous renal cancer cells.

Tani K, Nakazaki Y, Hase H, Takahashi K, Azuma M, Ohata J, Kitamura R, Komine F, Oiwa M, Masunaga A, Maekawa T, Satoh N, Adachi D, Soda Y, Machida U, Endo M, Yamazaki T, Watari K, Tojo A, Yamashita N, Tomikawa S, Eriguchi M, Hamada H, Wakumoto Y, Hanazawa K, Okumura K.

Cancer Chemother Pharmacol. 2000;46 Suppl:S73-6.

PMID:
10950152
34.

TCR-Vbeta repertoire analysis with RT-PCR was useful for the early detection of pulmonary relapsed T-cell lymphoma after autologous peripheral blood stem cell transplantation.

Hase H, Tani K, Nagayama H, Watari K, Takahashi S, Ooi J, Shirafuji N, Iseki T, Nakazaki Y, Yamashita T, Nakamura T, Masunaga A, Maekawa T, Tojo A, Asano S.

Am J Hematol. 2000 Jun;64(2):124-7.

35.

The common marmoset as a target preclinical primate model for cytokine and gene therapy studies.

Hibino H, Tani K, Ikebuchi K, Wu MS, Sugiyama H, Nakazaki Y, Tanabe T, Takahashi S, Tojo A, Suzuki S, Tanioka Y, Sugimoto Y, Nakahata T, Asano S.

Blood. 1999 May 1;93(9):2839-48.

PMID:
10216078
36.

Vaccine effect of granulocyte-macrophage colony-stimulating factor or CD80 gene-transduced murine hematopoietic tumor cells and their cooperative enhancement of antitumor immunity.

Nakazaki Y, Tani K, Lin ZT, Sumimoto H, Hibino H, Tanabe T, Wu MS, Izawa K, Hase H, Takahashi S, Tojo A, Azuma M, Hamada H, Mori S, Asano S.

Gene Ther. 1998 Oct;5(10):1355-62.

37.

Superiority of interleukin-12-transduced murine lung cancer cells to GM-CSF or B7-1 (CD80) transfectants for therapeutic antitumor immunity in syngeneic immunocompetent mice.

Sumimoto H, Tani K, Nakazaki Y, Tanabe T, Hibino H, Wu MS, Izawa K, Hamada H, Asano S.

Cancer Gene Ther. 1998 Jan-Feb;5(1):29-37.

PMID:
9476964
38.

GM-CSF and B7-1 (CD80) co-stimulatory signals co-operate in the induction of effective anti-tumor immunity in syngeneic mice.

Sumimoto H, Tani K, Nakazaki Y, Tanabe T, Hibino H, Hamada H, Azuma M, Asano S.

Int J Cancer. 1997 Nov 14;73(4):556-61.

39.

Transduction of LacZ gene into leukemia cells using viral vectors of retrovirus and adenovirus.

Tani K, Lin T, Hibino H, Takahashi K, Nakazaki Y, Takahashi S, Nagayama H, Ozawa K, Saitoh I, Mulligan R, et al.

Leukemia. 1995 Oct;9 Suppl 1:S64-5.

PMID:
7475316

Supplemental Content

Loading ...
Support Center